title: Rivaroxaban (xarelto) for the prevention of thromboembolic disease: an inside look at the oral direct factor xa inhibitor.
authors: Younos Abdulsattar and Rahul Bhambri are pharmacy students at Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, in Brooklyn, New York. Dr. Nogid is Assistant Professor of Pharmacy Practice at the university and a Critical Care Pharmacist at Brookdale University Hospital & Medical Center in Brooklyn. Drug Forecast is a regular column coordinated by Alan Caspi, PhD, PharmD, MBA, President of Caspi & Associates in New York, New York.
authors: Younos
authors: Y
authors: Abdulsattar
authors: Rahul
authors: R
authors: Bhambri
authors: Anna
authors: A
authors: Nogid